Unlock instant, AI-driven research and patent intelligence for your innovation.

Spiroindolinones and Therapeutic Uses Thereof

a technology of spiroindolinone and small molecules, which is applied in the field of spiroindolinonecontaining small molecules, can solve the problems of thrombocytopenia, headache, anaphylaxis and rash, and the resistance to fluconazole and other azole drugs remains a major problem

Active Publication Date: 2020-05-07
RGT UNIV OF CALIFORNIA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention is about small molecules called spiroindolinones and their use in making medications. The molecules have certain structures and can be used to treat various disorders. The invention also includes methods for making these molecules and their stereoselective versions. The technical effects of the invention include providing new molecules for the treatment of disorders and methods for their manufacture.

Problems solved by technology

However, there are reports of side effects, including hepatitis, leukopenia, thrombocytopenia, gastrointestinal distress, headache, anaphylaxis and rash.
Moreover, resistance to fluconazole and other azole drugs remains a major problem particularly among immunocompromised patients.
Accordingly, it has not been possible to determine which combination of stereochemical configuration and functional groups are important for biological activity by comparing active compounds with inactive compounds.
Spiroindolinones with a relative stereochemical configuration like those in FIGS. 2b and 4a can not be efficiently synthesized by methods known in the prior art.
2b, with a relative stereochemistry that is correlated with potent antifungal synergy, could not be efficiently synthesized using methods known in the prior art.
However, after a few hours the reaction mixture became cloudy.
It is widely recognized that the average molecular weight and complexity of newly approved oral drugs has been increasing with each year.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Spiroindolinones and Therapeutic Uses Thereof
  • Spiroindolinones and Therapeutic Uses Thereof
  • Spiroindolinones and Therapeutic Uses Thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0104]Turning now to the drawings and data, small molecules capable of treating disorders, including fungal and microbial infections, from a variety of therapeutic mechanisms including inhibiting the biochemical pathways in eukaryotic cells and enhancing the antifungal or antimicrobial activity of other antifungal or antimicrobial agents such as fluconazole, medicaments formed from these small molecules, methods for the treatment of fungal or microbial disorders using such therapeutics are disclosed, and stereoselective methods for preparing such compounds. The invention involves small molecules containing spiroindolinones attached to a central pyrrolidine ring that is fused to a succinimide (FIG. 1). In some embodiments, the small molecules are spiroindolinones containing an additional ring comprised of Y—X fused to the central pyrrolidine (FIGS. 2a and 2b). Additional embodiments of the spiroindolinone small molecules incorporate spirocyclic compounds in which the groups R8 and R9...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molar densityaaaaaaaaaa
Molar densityaaaaaaaaaa
Molar densityaaaaaaaaaa
Login to View More

Abstract

Small molecules comprised of spiroindolinone analogues are provided. Some spiroindolinones are provided with a particular relative stereochemistry in which the indolone carbonyl and all three hydrogens are on the same face of the central pyrrolidine ring. A stereoselective method of synthesis is provided for making some of the spiroindolinones described above. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, fungal infections. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.

Description

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH[0001]This invention was made with Governmental support under Grant No. 1R01 Al099190 awarded by the National Institute of Health. The government has certain rights in the inventionFIELD OF THE INVENTION[0002]The invention is generally directed to spiroindolinone-containing small molecules and pharmaceutically acceptable salts thereof, methods of manufacturing such small molecules, and methods for the treatment of fungal or microbial disorders using such therapeutics.BACKGROUND[0003]Candida sp account for 80% of major systemic fungal infections. (Revankar, S. G.; Sobel, J. D., Eds. Candidiasis (Invasive). Merck Manual, 2014) The mortality rate for invasive candidiasis has been estimated around 40%. (Ahmadi, A., et al. JRSM Open 2014, 5, 1-10) Azoles remain a first-line treatment for many systemic fungal infections. All azole antifungal drugs act on the same fungal enzyme 14α-demethylase, but exhibit varying levels of activity against d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D487/14A61P31/10
CPCA61K45/06A61P31/10C07D487/14A61K31/404A61K31/4174A61K31/4196A61K31/422A61K31/496A61K31/4985A61K31/506C07D487/10A61K2300/00C07D487/20
Inventor VAN VRANKEN, DAVID LEELIU, HAOPINGPREMACHANDRA, IIANDARI DEWAGEWANG, FUQIANGSHEN, CHENGTIANSCOTT, KEVIN ANDRELANE, SHELLEY REN-ANMOOD, AARON DAVIDHIEW, STANLEY CHUNGSING
Owner RGT UNIV OF CALIFORNIA